189 related articles for article (PubMed ID: 8796998)
21. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.
Mueller BM
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():65-80. PubMed ID: 8814995
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.
Niedbala MJ; Sartorelli AC
Cancer Commun; 1990; 2(5):189-99. PubMed ID: 2142433
[TBL] [Abstract][Full Text] [Related]
23. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM
Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205
[TBL] [Abstract][Full Text] [Related]
24. Structural biochemistry and activation of matrix metalloproteases.
Kleiner DE; Stetler-Stevenson WG
Curr Opin Cell Biol; 1993 Oct; 5(5):891-7. PubMed ID: 8240832
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis.
Stetler-Stevenson WG; Liotta LA; Kleiner DE
FASEB J; 1993 Dec; 7(15):1434-41. PubMed ID: 8262328
[TBL] [Abstract][Full Text] [Related]
26. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.
Carmeliet P; Moons L; Lijnen R; Baes M; Lemaître V; Tipping P; Drew A; Eeckhout Y; Shapiro S; Lupu F; Collen D
Nat Genet; 1997 Dec; 17(4):439-44. PubMed ID: 9398846
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues.
Parry MA; Zhang XC; Bode I
Trends Biochem Sci; 2000 Feb; 25(2):53-9. PubMed ID: 10664583
[TBL] [Abstract][Full Text] [Related]
28. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
Meissauer A; Kramer MD; Schirrmacher V; Brunner G
Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
[TBL] [Abstract][Full Text] [Related]
29. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
30. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
Quax PH; de Bart AC; Schalken JA; Verheijen JH
Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
[TBL] [Abstract][Full Text] [Related]
31. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
[TBL] [Abstract][Full Text] [Related]
32. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
33. Serine protease and metallo protease cascade systems involved in pericellular proteolysis.
Quigley JP; Berkenpas MB; Aimes RT; Chen JM
Cell Differ Dev; 1990 Dec; 32(3):263-75. PubMed ID: 1965954
[TBL] [Abstract][Full Text] [Related]
34. Tissue inhibitors of matrix metalloproteinases in cancer.
Blavier L; Henriet P; Imren S; Declerck YA
Ann N Y Acad Sci; 1999 Jun; 878():108-19. PubMed ID: 10415723
[TBL] [Abstract][Full Text] [Related]
35. Fibrinolysis: the key to new pathogenetic mechanisms.
Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
[TBL] [Abstract][Full Text] [Related]
36. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells.
Huet E; Brassart B; Cauchard JH; Debelle L; Birembaut P; Wallach J; Emonard H; Polette M; Hornebeck W
Clin Exp Metastasis; 2002; 19(2):107-17. PubMed ID: 11964074
[TBL] [Abstract][Full Text] [Related]
37. The plasmin system in airway remodeling.
Kucharewicz I; Kowal K; Buczko W; Bodzenta-Łukaszyk A
Thromb Res; 2003; 112(1-2):1-7. PubMed ID: 15013265
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.
Hiraoka N; Allen E; Apel IJ; Gyetko MR; Weiss SJ
Cell; 1998 Oct; 95(3):365-77. PubMed ID: 9814707
[TBL] [Abstract][Full Text] [Related]
39. Tumor invasion, proteolysis, and angiogenesis.
Thorgeirsson UP; Lindsay CK; Cottam DW; Gomez DE
J Neurooncol; 1994; 18(2):89-103. PubMed ID: 7525888
[TBL] [Abstract][Full Text] [Related]
40. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells.
Koli K; Keski-Oja J
Cell Growth Differ; 2000 Apr; 11(4):221-9. PubMed ID: 10775039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
